News

Debate weighs merits of both modalities; further research may elucidate preferences

The typical signs and symptoms of shunt malfunction include headache, neck pain, malaise, nausea and vomiting, mental status changes, increased blood pressure, or seizure.

Inhibition of PKC shown to affect changes in retinal blood flow as well as leukocyte adhesion

Inflammatory mechanisms, infectious agents, and environmental and systemic co-factors explored

Glaucoma agent may be more protective of optic nerve by blunting IOP spikes, expert says

New this year: A rapid-fire paper session consisting of almost 30 cutting-edge refractive surgery-based papers from around the world.

San Diego-The key to achieving the most from refractive surgery is an understanding of the biomechanics of the refractive procedures in the eye coupled with advances in pharmaceuticals to facilitate wound healing.

When should intraocular lymphoma be considered, and when it is suspected what steps should be taken to make the diagnosis?

The risk of endophthalmitis after clear corneal surgery was significantly higher compared with both scleral and limbal incisions.

Presence of pigmentation may be inhibitory factor for blood vessel growth, researchers report

However, IOP remains most important risk factor for blindness

Fixed combination compares favorably with concomitant use of prostaglandin analogue, beta-blocker

Waltham, MA-Interleukin Genetics Inc. has received a U.S. patent for a method that uses specific genetic markers to identify people with diabetes who are at an increased risk of retinopathy.

Des Plaines, IL-First-quarter 2004 sales of Addition Technology Inc.'s micro-thin prescription inserts (Intacs) increased 57% over the same period a year ago and 93% over the previous quarter, according to the company.

Irvine, CA-Medennium Inc. is working with GD Services Inc. of Newport Beach, CA, to help raise money for its SmartIOL, an injectable, full-sized, accommodating IOL under development.

New York-Eyetech Pharmaceuticals and Archemix Corp. will collaborate on the research and development of aptamers for use in the treatment of ophthalmic diseases.

Fort Lauderdale, FL-The ARVO Foundation, the non-profit research support group for the Association for Research in Vision and Ophthalmology (ARVO), received a $500,000 grant from Pfizer Ophthalmics, New York, to fund in partnership interdisciplinary research conferences and awards to promote research related to preventing blindness.

Progressive condition involving tissue damage is related to IOP, not necessarily elevated pressure

Branded drug with lower concentration does offer a better side effect profile than generics

Surgeons should reconsider system that allows for rapid rise in vacuum, increased efficiency

Surgeons should reconsider system that allows for rapid rise in vacuum, increased efficiency

'The low vision population continuesto expand.'Bruce P. Rosenthal, OD

Positive effect seen with azelastine solution in early, late phases of allergic response

New publication covers the Edo, Meiji eras, including Western influences

AdvaMed works to clear policy hurdles, making it easier for device manufacturers to bring their products to the marketplace.

With Advanced Medical Optics' (AMO) acquisition of the Pfizer surgical sector, it bought a lot more than just products.

Analyses of complication and adverse event data demonstrate the excellent safety profile of the capsular tension ring.

In addition to preventing allergic symptoms, an eye drop helps to improve the quality of the ocular surface.